US Stock MarketDetailed Quotes

Outlook Therapeutics (OTLK)

Watchlist
  • 0.5100
  • +0.0040+0.79%
Close Jan 22 16:00 ET
  • 0.5151
  • +0.0051+1.00%
Post 19:57 ET
32.70MMarket Cap-0.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Outlook Therapeutics (OTLK) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
Total revenue
1.41M
-91.79K
1.51M
0
0
0
0
0
0
0
Operating revenue
--1.41M
---91.79K
--1.51M
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
1.36M
916.52K
439.82K
0
0
0
Gross profit
57.21K
-1.01M
1.07M
0
0
0
Operating expense
-6.39%67.12M
-28.72%16.31M
-14.05%16.81M
-34.57%12.39M
109.31%21.61M
34.97%71.7M
83.62%22.88M
7.83%19.56M
176.98%18.94M
-34.20%10.32M
Selling and administrative expenses
33.39%39.94M
-0.26%10.33M
15.77%9.68M
47.02%7.98M
106.20%11.95M
12.25%29.94M
37.78%10.35M
18.76%8.36M
-13.70%5.43M
-0.55%5.79M
-General and administrative expense
33.39%39.94M
-0.26%10.33M
15.77%9.68M
47.02%7.98M
106.20%11.95M
12.25%29.94M
37.78%10.35M
18.76%8.36M
-13.70%5.43M
-0.55%5.79M
Research and development costs
-34.92%27.18M
-52.26%5.98M
-36.31%7.13M
-67.38%4.41M
113.28%9.66M
57.88%41.76M
153.29%12.52M
0.90%11.2M
2,378.94%13.51M
-54.07%4.53M
Operating profit
6.47%-67.06M
24.32%-17.31M
19.50%-15.75M
34.57%-12.39M
-109.31%-21.61M
-34.97%-71.7M
-83.62%-22.88M
-7.83%-19.56M
-176.98%-18.94M
34.20%-10.32M
Net non-operating interest income expense
91.41%-193.39K
-172.69%-174.42K
-112.20%-49.35K
99.40%-18.5K
-74.09%48.88K
-44.31%-2.25M
-21.54%239.95K
2.37%404.59K
-1,742.24%-3.08M
107.71%188.68K
Non-operating interest income
-90.10%89.74K
----
----
----
-74.09%48.88K
-6.72%906.15K
-21.59%239.95K
2.29%404.59K
----
--188.68K
Non-operating interest expense
-91.03%283.13K
-60.35%264.16K
--49.35K
----
----
24.72%3.16M
323,297.57%666.2K
--0
----
----
Total other finance cost
----
----
----
-99.40%18.5K
----
----
----
----
1,742.24%3.08M
----
Other net income (expense)
332.53%3.28M
-90.68%2.64M
-106.85%-4.35M
63.21%-33.94M
3,830.20%38.94M
67.16%-1.41M
3,482.31%28.33M
2,270.32%63.57M
-6,834,132.07%-92.26M
-98.48%-1.04M
Gain on sale of security
11.33%43.02M
-90.70%2.68M
-103.36%-2M
99.91%-51.15K
3,824.30%38.97M
75,781.38%38.64M
209,078.42%28.85M
506,136.45%59.45M
-372,395.68%-58.13M
-3,557.84%-1.05M
Earnings from equity interest
-39.97%-141.01K
-165.95%-40.42K
46.29%-30.88K
-19.00%-36.41K
-1,406.71%-33.3K
-816.00%-100.74K
-82.01%-15.2K
-699.90%-57.5K
-80.34%-30.6K
-88.15%2.55K
Special income (charges)
----
----
----
----
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
0.88%-39.6M
99.87%-641
-155.72%-2.32M
0.71%-33.86M
-31.32%-1.3M
-963.56%-39.95M
39.74%-508K
243.32%4.17M
-1,136,485.60%-34.1M
---993K
Income before tax
15.11%-63.98M
-360.88%-14.85M
-145.38%-20.15M
59.44%-46.35M
255.46%17.38M
-27.78%-75.36M
143.81%5.69M
314.80%44.41M
-1,618.20%-114.29M
40.10%-11.18M
Income tax
-55,522.46%-1.55M
-1.55M
0
0.00%2.8K
0.00%2.8K
0
0
0.00%2.8K
Net income
17.17%-62.42M
-333.56%-13.29M
-145.38%-20.15M
59.44%-46.36M
255.46%17.38M
-27.78%-75.37M
143.81%5.69M
314.80%44.41M
-1,617.52%-114.29M
40.10%-11.18M
Net income continuous Operations
17.17%-62.42M
-333.56%-13.29M
-145.38%-20.15M
59.44%-46.36M
255.46%17.38M
-27.78%-75.37M
143.81%5.69M
314.80%44.41M
-1,617.52%-114.29M
40.10%-11.18M
Minority interest income
Net income attributable to the parent company
17.17%-62.42M
-333.56%-13.29M
-145.38%-20.15M
59.44%-46.36M
255.46%17.38M
-27.78%-75.37M
143.81%5.69M
314.80%44.41M
-1,617.52%-114.29M
40.10%-11.18M
Preferred stock dividends
Other preferred stock dividends
0
66.96M
Net income attributable to common stockholders
17.17%-62.42M
-333.56%-13.29M
10.62%-20.15M
59.44%-46.36M
255.46%17.38M
-27.78%-75.37M
143.81%5.69M
-9.05%-22.55M
-1,617.52%-114.29M
40.10%-11.18M
Basic earnings per share
55.91%-1.79
-125.00%-0.19
-128.80%-0.55
81.27%-1.5
183.72%0.72
13.98%-4.06
176.77%0.76
218.63%1.91
-1,440.38%-8.01
46.25%-0.86
Diluted earnings per share
55.91%-1.79
-125.00%-0.19
38.20%-0.55
81.27%-1.5
183.72%0.72
13.98%-4.06
176.77%0.76
44.72%-0.89
-1,440.38%-8.01
46.25%-0.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023
Total revenue 1.41M-91.79K1.51M0000000
Operating revenue --1.41M---91.79K--1.51M--0--0--0--0--0--0--0
Cost of revenue 1.36M916.52K439.82K000
Gross profit 57.21K-1.01M1.07M000
Operating expense -6.39%67.12M-28.72%16.31M-14.05%16.81M-34.57%12.39M109.31%21.61M34.97%71.7M83.62%22.88M7.83%19.56M176.98%18.94M-34.20%10.32M
Selling and administrative expenses 33.39%39.94M-0.26%10.33M15.77%9.68M47.02%7.98M106.20%11.95M12.25%29.94M37.78%10.35M18.76%8.36M-13.70%5.43M-0.55%5.79M
-General and administrative expense 33.39%39.94M-0.26%10.33M15.77%9.68M47.02%7.98M106.20%11.95M12.25%29.94M37.78%10.35M18.76%8.36M-13.70%5.43M-0.55%5.79M
Research and development costs -34.92%27.18M-52.26%5.98M-36.31%7.13M-67.38%4.41M113.28%9.66M57.88%41.76M153.29%12.52M0.90%11.2M2,378.94%13.51M-54.07%4.53M
Operating profit 6.47%-67.06M24.32%-17.31M19.50%-15.75M34.57%-12.39M-109.31%-21.61M-34.97%-71.7M-83.62%-22.88M-7.83%-19.56M-176.98%-18.94M34.20%-10.32M
Net non-operating interest income expense 91.41%-193.39K-172.69%-174.42K-112.20%-49.35K99.40%-18.5K-74.09%48.88K-44.31%-2.25M-21.54%239.95K2.37%404.59K-1,742.24%-3.08M107.71%188.68K
Non-operating interest income -90.10%89.74K-------------74.09%48.88K-6.72%906.15K-21.59%239.95K2.29%404.59K------188.68K
Non-operating interest expense -91.03%283.13K-60.35%264.16K--49.35K--------24.72%3.16M323,297.57%666.2K--0--------
Total other finance cost -------------99.40%18.5K----------------1,742.24%3.08M----
Other net income (expense) 332.53%3.28M-90.68%2.64M-106.85%-4.35M63.21%-33.94M3,830.20%38.94M67.16%-1.41M3,482.31%28.33M2,270.32%63.57M-6,834,132.07%-92.26M-98.48%-1.04M
Gain on sale of security 11.33%43.02M-90.70%2.68M-103.36%-2M99.91%-51.15K3,824.30%38.97M75,781.38%38.64M209,078.42%28.85M506,136.45%59.45M-372,395.68%-58.13M-3,557.84%-1.05M
Earnings from equity interest -39.97%-141.01K-165.95%-40.42K46.29%-30.88K-19.00%-36.41K-1,406.71%-33.3K-816.00%-100.74K-82.01%-15.2K-699.90%-57.5K-80.34%-30.6K-88.15%2.55K
Special income (charges) ----------------------0--0--0--0----
Other non- operating income (expenses) 0.88%-39.6M99.87%-641-155.72%-2.32M0.71%-33.86M-31.32%-1.3M-963.56%-39.95M39.74%-508K243.32%4.17M-1,136,485.60%-34.1M---993K
Income before tax 15.11%-63.98M-360.88%-14.85M-145.38%-20.15M59.44%-46.35M255.46%17.38M-27.78%-75.36M143.81%5.69M314.80%44.41M-1,618.20%-114.29M40.10%-11.18M
Income tax -55,522.46%-1.55M-1.55M00.00%2.8K0.00%2.8K000.00%2.8K
Net income 17.17%-62.42M-333.56%-13.29M-145.38%-20.15M59.44%-46.36M255.46%17.38M-27.78%-75.37M143.81%5.69M314.80%44.41M-1,617.52%-114.29M40.10%-11.18M
Net income continuous Operations 17.17%-62.42M-333.56%-13.29M-145.38%-20.15M59.44%-46.36M255.46%17.38M-27.78%-75.37M143.81%5.69M314.80%44.41M-1,617.52%-114.29M40.10%-11.18M
Minority interest income
Net income attributable to the parent company 17.17%-62.42M-333.56%-13.29M-145.38%-20.15M59.44%-46.36M255.46%17.38M-27.78%-75.37M143.81%5.69M314.80%44.41M-1,617.52%-114.29M40.10%-11.18M
Preferred stock dividends
Other preferred stock dividends 066.96M
Net income attributable to common stockholders 17.17%-62.42M-333.56%-13.29M10.62%-20.15M59.44%-46.36M255.46%17.38M-27.78%-75.37M143.81%5.69M-9.05%-22.55M-1,617.52%-114.29M40.10%-11.18M
Basic earnings per share 55.91%-1.79-125.00%-0.19-128.80%-0.5581.27%-1.5183.72%0.7213.98%-4.06176.77%0.76218.63%1.91-1,440.38%-8.0146.25%-0.86
Diluted earnings per share 55.91%-1.79-125.00%-0.1938.20%-0.5581.27%-1.5183.72%0.7213.98%-4.06176.77%0.7644.72%-0.89-1,440.38%-8.0146.25%-0.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -